BRIEF-Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY

Reuters09-30

Sept 30 (Reuters) - Microbot Medical Inc :

* MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP

* MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED FOLLOW-UP, TRIAL TO FINISH AHEAD OF SCHEDULE

* MICROBOT MEDICAL INC - ON TRACK FOR FDA 510$(K)$ SUBMISSION BY END OF 2024

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2471324807?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-30 20:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2471324807","market":"us","top_or_hot":-1,"title":"BRIEF-Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY","media":"Reuters","content":"<html><body><p>Sept 30 (Reuters) - <a href=\"https://laohu8.com/S/MBOT\">Microbot Medical Inc</a>   :</p><p>   * MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP</p><p>   * MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED FOLLOW-UP, TRIAL TO FINISH AHEAD OF SCHEDULE</p><p>   * MICROBOT MEDICAL INC - ON TRACK FOR FDA 510<a href=\"https://laohu8.com/S/K\">$(K)$</a> SUBMISSION BY END OF 2024</p><p>Source text for Eikon:   Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-30 20:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sept 30 (Reuters) - Microbot Medical Inc   :   * MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2471324807","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2471324807","pubTimestamp":1727700531,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 30  - Microbot Medical Inc   :   * MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP   * MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED FOLLOW-UP, TRIAL TO FINISH AHEAD OF SCHEDULE   * MICROBOT MEDICAL INC - ON TRACK FOR FDA 510 SUBMISSION BY END OF 2024Source text for Eikon:   Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4504":"桥水持仓","BK4212":"包装食品与肉类","BK4082":"医疗保健设备","MBOT":"Microbot Medical Inc","K":"家乐氏"},"translate_title":"简介-Microbot Medical加速LIBERTY人体临床试验的患者招募","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"K":1,"MBOT":0.9},"content_text":"Sept 30 (Reuters) - Microbot Medical Inc   :   * MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP   * MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED FOLLOW-UP, TRIAL TO FINISH AHEAD OF SCHEDULE   * MICROBOT MEDICAL INC - ON TRACK FOR FDA 510$(K)$ SUBMISSION BY END OF 2024Source text for Eikon:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2471324807"}